首页 > 市场调查报告书 > 医疗设备

医学影像诊断

市场调查报告书

商品编码

1542871

全球乳房病变定位方法市场 - 2024-2031

Global Breast Lesion Localization Methods Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球乳房病变定位市场达3.6387亿美元，预计2031年将达到7.9515亿美元，2024-2031年预测期间复合年增长率为10.5%。

乳房病灶定位方法是手术前的程序，将放射性同位素、磁示踪剂和电线等定位装置插入检测到癌症的部位，以便在手术切除时定位不可触及的病灶。

乳房病灶定位方法程序是根据病灶类型及其位置，使用超音波、磁振造影 (MRI) 或乳房 X 光摄影等手术导引系统进行。随着乳房病变的早期检测，高达 50% 的肿瘤切除术和外科活检手术中必须进行定位程序，以确保准确切除目标病变。

市场动态：

驱动程式和限制

乳癌发生率增加

女性乳癌发生率的增加是全球乳房病变定位方法市场的主要驱动因素。定位步骤确保外科医师在手术过程中能够准确识别和切除病灶。

例如，根据世界癌症研究基金会的数据，2022 年女性乳癌新增病例为 2,296,840 例。

每个国家都有大量乳癌患者，这提高了在地化的需求。例如，中国有超过 357,161 人患有乳癌，而美国有近 274、375 人患有乳癌。因此，乳癌患者数量的增加可能会促进市场成长。

先进技术成本高

先进的定位方法，例如放射性种子定位（RSL）和磁性种子定位（MSL），通常需要使用昂贵的专用设备。除了初始投资之外，这些技术可能还需要持续维护、专用设备和材料，这会增加整体成本。这可能会给医疗保健提供者带来经济负担。

细分市场分析

全球乳房病变定位市场根据方法、设备和区域进行细分。

有线引导定位 (WGL) 领域预计将主导市场份额

线导本地化占有最大的市场份额，预计在预测期内仍将占据主导地位。这可以归因于其成立较早和最终用户的采用率较高。这种定位提供了病变的精确定位，尤其是微小或难以使用其他方法可视化的病变。

导丝定位是一种成熟且常用的乳房手术指导方法，具有悠久的成功历史。该程序受到良好监管，具有较高的安全性和有效性，有助于确保其持续使用和采用。因此，上述因素预计将保持该细分市场的市场份额。

市场地域占有率

北美预计将在乳房病变定位市场份额中占据重要地位

北美在全球乳房病变定位方法市场中占有相当大的份额，这主要归因于该地区乳癌的高盛行率等因素。它拥有广泛的患者群体和重要的医疗公司。

此外，美国等已开发地区的认知度较高、医疗保健支出较高、研究设施和实验室的存在、该地区大多数知名企业开展的广泛研究活动以及先进医疗技术的早期采用有助于推动区域市场。

例如，根据美国疾病管制与预防中心2022年的报告，2021年女性新增乳癌病例为272,454例，2022年有42,211名女性死于乳癌。

此外，根据美国癌症协会的数据，预计到 2024 年，女性中将诊断出约 310,720 例新的侵袭性乳癌病例，并且将诊断出约 56,500 例新的乳管原位癌 (DCIS) 病例。因此，乳癌病例数量的增加预计将增加对定位方法的需求，从而使该地区处于主导地位。

Breast Lesion Localization Methods procedure is carried out using surgical guidance systems such as ultrasound, Magnetic Resonance Imaging (MRI), or mammography, depending on the type of lesion and its location. With earlier detection of breast lesions, localization procedures have become necessary in up to 50% of all lumpectomy and surgical biopsy procedures to ensure accurate removal of the target lesion.

Market Dynamics: Drivers & Restraints

Increasing incidence of breast cancer

The increasing incidences of breast cancer among women are the predominant driving factor of the global market for breast lesion localization methods. The localization step ensures that the surgeon can accurately identify and excise the lesion during the surgery.

For instance, according to the World Cancer Research Fund International, it is stated that there were 2,296,840 new cases of breast cancer in 2022 among women.

Every country contains a large number of breast cancer patients which is raising the need for localization. For instance, China accounts for over 357,161 individuals suffering from breast cancer and the U.S. accounts for almost 274, 375 individuals with breast cancer. Thus, the increasing number of individuals with breast cancer could raise the market growth.

High cost of advanced technologies

Advanced localization approaches, such as radioactive seed localization (RSL) and magnetic seed localization (MSL), often require the use of costly specialized equipment. Beyond the initial investment, these technologies may necessitate ongoing maintenance, specialized equipment, and materials, which increases the entire cost. This may cause a financial burden on healthcare providers.

Market Segment Analysis

The global breast lesion localization market is segmented based on method, devices and region.

Wire-Guided Localization (WGL) segment is expected to dominate the market share

The wire-guided localization share holds the most significant market share and is expected to remain dominant over the forecast period. It can be attributed to its early establishment and higher adoption rate among end-users. This localization provides precise localization of lesions, especially lesions that are tiny or difficult to visualize using other methods.

Wire-guided localization is a well-established and commonly used approach for directing breast surgery, with a long history of success. The procedure is well-regulated and has a high safety and efficacy profile, which helps to ensure its continued use and adoption. Thus, the above factors are expected to hold the segment in the market share.

Market Geographical Share

North America is expected to hold a significant position in the breast lesion localization market share

North America holds a substantial share of the global breast lesion localization methods market, and it is primarily attributed to factors such as the high prevalence of breast cancer in the region. It has a broad base of the patient population and the presence of significant medical companies.

Moreover, the higher awareness in developed areas such as the U.S., high healthcare expenditure, the presence of research facilities and labs, the extensive research activities undertaken by a majority of prominent players in the area, and the early adoption of advanced medical technologies help propel the regional market.

For instance, according to the Centers for Disease Control and Prevention report in 2022, 272,454 new breast cancers were reported in females in 2021, and in 2022, 42,211 females died from breast cancer.

Additionally, according to the American Cancer Society, Inc., it is estimated that about 310,720 new cases of invasive breast cancer will be diagnosed in women in 2024, and about 56,500 new cases of ductal carcinoma in situ (DCIS) will be diagnosed. Thus, the increasing number of breast cancer cases is expected to increase the demand for localization methods, thus holding the region in the dominant position.

Market Segmentation

By Method

Wire-Guided Localization (WGL)

Magnetic Tracers

Electromagnetic Reflectors

Radio Guided Occult-Lesion Localization (ROLL)

Radioactive-Seed Localization (RSL)

Others

Breast Biopsy Marker Localization

Others

By Devices

Radioactive Seeds

Radar Reflectors

Magnetic Seeds

Radiofrequency Identification Tag Localizers (RFIDs)

Wires

Coils

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Becton, Dickinson, and Company, Sterylab S.r.l., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Hologic Inc., Cook Medical, Mammotome, Merit Medical Systems, Inc., Theragenics Corporation and Mermaid Medical among others.

Why Purchase the Report?

To visualize the global breast lesion localization market segmentation based on type, drug type, route of administration, distribution channel, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of breast lesion localization market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global breast lesion localization market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Method
3.2. Snippet by Devices
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing incidence of breast cancer
- 4.1.2. Restraints
  - 4.1.2.1. High cost of advanced technologies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Method

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 6.1.2. Market Attractiveness Index, By Method
6.2. Wire-Guided Localization (WGL) *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Magnetic Tracers
6.4. Electromagnetic Reflectors
- 6.4.1. Radio Guided Occult-Lesion Localization (ROLL)
- 6.4.2. Radioactive-Seed Localization (RSL)
- 6.4.3. Others
6.5. Breast Biopsy Marker Localization
6.6. Others

7. By Devices

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 7.1.2. Market Attractiveness Index, By Devices
7.2. Radioactive Seeds*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Radar Reflectors
7.4. Magnetic Seeds
7.5. Radiofrequency Identification Tag Localizers (RFIDs)
7.6. Wires
7.7. Coils
7.8. Others

8. By Region

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
  - 8.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  - 8.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.3.1. The U.S.
  - 8.2.3.2. Canada
  - 8.2.3.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
  - 8.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.4.1. Germany
  - 8.3.4.2. UK
  - 8.3.4.3. France
  - 8.3.4.4. Italy
  - 8.3.4.5. Spain
  - 8.3.4.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
  - 8.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.4.1. Brazil
  - 8.4.4.2. Argentina
  - 8.4.4.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
  - 8.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.4.1. China
  - 8.5.4.2. India
  - 8.5.4.3. Japan
  - 8.5.4.4. South Korea
  - 8.5.4.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
  - 8.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Becton, Dickinson, and Company *
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Sterylab S.r.l.
10.3. SOMATEX Medical Technologies GmbH
10.4. Argon Medical Devices
10.5. Hologic Inc.
10.6. Cook Medical
10.7. Mammotome
10.8. Merit Medical Systems, Inc.
10.9. Theragenics Corporation
10.10. Mermaid Medical (*LIST NOT EXHAUSTIVE)